Topline Phase 2 Results Reported for Novel AntidepressantTopline Phase 2 Results Reported for Novel Antidepressant

Positive, topline results from a phase 2 trial have been reported for a novel antidepressant as an adjunctive treatment for treatment-resistant major depression. Medscape Medical News (Source: Medscape Today Headlines)

via Original Article